Waterloo Institute for Nanotechnology
Mike & Ophelia Lazaridis Quantum-Nano Centre, QNC 3606
University of Waterloo
200 University Avenue West,
Waterloo, ON N2L 3G1
519-888-4567, ext. 38654
win-office@uwaterloo.ca
Curing and preventing the outspread of diseases, infections and abnormalities. WIN members are engineering new methods of medical practices and making innovative advancements in this thematic area of Therapeutics and Theranostics. This includes but is not limited to targeted drug delivery, tissue engineering, minimally invasive treatment of diseases, immunotherapy, and medical imaging.
Emmanuel Ho (Pharmacy) received his PhD in Pharmaceutical Sciences from the University of Toronto and in 2017 joined the School of Pharmacy at the University of Waterloo. His current research program is focused on the development and characterization of innovative nanomedicines, medical devices, and biomaterials for imaging, treatment, and prevention of diseases including HIV/AIDS, cancer, and chronic wounds.
Alfred Yu (ECE) received PhD degree from the University of Toronto, started his independent academic career at the University of Hong Kong, and relocated to the University of Waterloo in 2015. He carries out research in ultrasound imaging using nanomaterials as contrast agents.
Waterloo Institute for Nanotechnology
Mike & Ophelia Lazaridis Quantum-Nano Centre, QNC 3606
University of Waterloo
200 University Avenue West,
Waterloo, ON N2L 3G1
519-888-4567, ext. 38654
win-office@uwaterloo.ca
The University of Waterloo acknowledges that much of our work takes place on the traditional territory of the Neutral, Anishinaabeg and Haudenosaunee peoples. Our main campus is situated on the Haldimand Tract, the land granted to the Six Nations that includes six miles on each side of the Grand River. Our active work toward reconciliation takes place across our campuses through research, learning, teaching, and community building, and is centralized within our Office of Indigenous Relations.